default author photo

Matt A. Price

International AIDS Vaccine Initiative, New York

125 Broad St

New York, NY 10004

United States

  • International AIDS Vaccine Initiative, New York

SCHOLARLY PAPERS

2

DOWNLOADS

85

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Acceptability and Applicability of Biometric Iris Scanning for the Identification and Follow Up of Highly Mobile Research Participants Living in Fishing Communities Along the Shores of Lake Victoria in Kenya, Tanzania, and Uganda

Number of pages: 24 Posted: 29 Nov 2022
Elialilia S. Okello, Philip Ayieko, Zachary Kwena, Gertrude Nanyonjo, Ubaldo Bahemuka, Matt A. Price, Elizabeth Bukusi, Ramadhan Hashim, Sarah Nakamanya, Brenda Okech, Monica Kuteesa, Bertha Oketch, Ali Ssetaala, Eugene Ruzagira, William Kidega, Patricia Fast, Freddie Kibengo, Heiner Grosskurth, Janet Seeley and Saidi Kapiga
Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Kenya Medical Research Institute (KEMRI), UVRI-IAVI HIV Vaccine Program, London School of Hygiene & Tropical Medicine - Uganda Research Unit, International AIDS Vaccine Initiative, New York, Kenya Medical Research Institute (KEMRI), National Institute for Medical Research (NIMR) - Mwanza Medical Research Centre, Government of Uganda - Uganda Virus Research Institute (UVRI), UVRI-IAVI HIV Vaccine Program, International AIDS Vaccine Initiative, Kenya Medical Research Institute (KEMRI), UVRI-IAVI HIV Vaccine Program, Government of Uganda - Uganda Virus Research Institute (UVRI), International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, Government of Uganda - Uganda Virus Research Institute (UVRI), Mwanza Intervention Trials Unit, London School of Hygiene & Tropical Medicine - Department of Global Health and Development and Mwanza Intervention Trials Unit
Downloads 52 (1,052,702)

Abstract:

Loading...

East Africa, fishing communities, Lake Victoria, acceptability, iris scanning, biometric identification

2.

Interleukin-21 Receptor Expression on CD8 T Cells: A Potential Biomarker of HIV-1 Disease State and Trajectory

Number of pages: 50 Posted: 14 Feb 2022
Jama Dalel, Jia Wei Teo, Seng K. Ung, Alisha McPherson, S. Lucas Black, Deborah L. W. Chong, Peter Hayes, Catherine N. Kibirige, The IAVI Protocol C. Investiga list, Matt A. Price, Sarah Joseph, Faith Osier, Nesrina Imami, Jill Gilmour and Julia Makinde
Imperial College London - IAVI Human Immunology Laboratory, Ministry of Education, Singapore, University College London - Tumour Immunodynamic Research Group, Imperial College London - IAVI Human Immunology Laboratory, Achilles Therapeutics UK Limited, St. George’s University of London - Institute for Infection and Immunity, Imperial College London - IAVI Human Immunology Laboratory, Imperial College London - IAVI Human Immunology Laboratory, Independent, International AIDS Vaccine Initiative, New York, Imperial College London - IAVI Human Immunology Laboratory, Imperial College London - IAVI Human Immunology Laboratory, Imperial College London - Centre for Immunology and Vaccinology, Imperial College London - Department of Infectious Disease and Imperial College London - IAVI Human Immunology Laboratory
Downloads 33 (1,290,922)

Abstract:

Loading...

HIV-1, Interleukin-21 receptor, Interleukin-21, Disease progression, Disease State, Cytotoxic T-Lymphocytes, CD8 T cells, CD360, CD38, HLA-DR, PD-1, exhaustion, Excessive Activation